Bellera, CA, Penel, N, Ouali, M, Bonvalot, S, Casali, PG, Nielsen, OS, Delannes, M, Litiere, S, Bonnetain, F, Dabakuyo, TS, Benjamin, RS, Blay, JY, Bui, BN, Collin, F, Delaney, TF, Duffaud, F, Filleron, T, Fiore, M, Gelderblom, H, George, S, Grimer, R, Grosclaude, P, Gronchi, A, Haas, R, Hohenberger, P, Issels, R, Italiano, A, Jooste, V, Krarup-Hansen, A, Pechoux, C, Mussi, C, Oberlin, O, Patel, S, Piperno-Neumann, S, Raut, C, Ray-Coquard, I, Rutkowski, P, Schuetze, S
, Sleijfer, S, Stoeckle, E, Glabbeke, M, Woll, P, Gourgou-Bourgade, S & Mathoulin-Pelissier, S 2015, '
Guidelines for time-to-event end point definitions in sarcomas and gastrointestinal stromal tumors (GIST) trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials)',
Annals of Oncology, vol. 26, no. 5, pp. 865-872.
https://doi.org/10.1093/annonc/mdu360